FIELD: medicine, genetics, biochemistry.
SUBSTANCE: invention relates to new NOS-variants or mutants that comprise structural modifications in site Akt-dependent phosphorylation. Modified NOS-proteins or peptides, in particular, human proteins or eNOS-peptides having change of amino acid residue corresponding to S/T in motif of the consensus-sequence RXRXXS/T of NOS-polypeptide of wild type and nucleic acid molecules encoding thereof can be used in genetic therapy and proteins and NOS-peptides can be used in screening methods of agents modulating activity of NOS. The advantage of invention involves the creature of new NOS-variants or mutants that can be used in genetic therapy.
EFFECT: valuable medicinal properties of mutants.
25 cl, 1 tbl, 9 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF KIDNEY CANCER | 2017 |
|
RU2752322C2 |
| CORYNEBACTERIUM GLUTAMICUM GENES ENCODING PROTEINS TAKING PART IN CARBON METABOLISM AND ENERGY PRODUCTION | 2005 |
|
RU2321634C2 |
| VARIANT OF MULTISUBSTRATE DEOXYRIBONUCLEOSIDE KINASE, MUTATED POLYNUCLEOTIDE ENCODING THE SAME, EXPRESSING VECTOR CONSTRUCT AND USES THEREOF | 2001 |
|
RU2297453C2 |
| DERIVATIVES OF FACTOR OF VII BLOOD COAGULATION | 2002 |
|
RU2338752C2 |
| IMPROVED ANTI-IGE-ANTIBODY (VARIANTS) AND METHOD FOR IMPROVING POLYPEPTIDES | 1998 |
|
RU2242515C2 |
| NOVEL ANTI-IL13 ANTIBODIES AND USE THEREOF | 2004 |
|
RU2487887C2 |
| USE OF INOS INHIBITORS TO INCREASE VIRAL YIELD IN CULTURE | 2014 |
|
RU2676733C2 |
| USE OF iNOS INHIBITORS TO INCREASE VIRUS YIELD IN CULTURE | 2014 |
|
RU2795456C2 |
| MUTANTS OF ACTIVATION INDUCED CYTIDINE DEAMINASE (AID) AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2537264C2 |
| RECEPTOR ANTAGONISTS FOR TREATING METASTATIC CANCER | 2009 |
|
RU2455026C2 |
